Author/Creator: Voß, Florian - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Voß, Florian

1. Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol. (December 2017)

Authors:: Koch, Andrea; Watz, Henrik; Maleki-Yazdi, M.; Bothner, Ulrich; Tetzlaff, Kay; Voß, Florian; McGarvey, Lorcan
Journal:: NPJ primary care respiratory medicine
Issue:: Volume 27(2017)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies. Issue 1 (December 2016)

Authors:: Singh, Dave; Gaga, Mina; Schmidt, Olaf; Bjermer, Leif; Grönke, Lars; Voß, Florian; Ferguson, Gary
Journal:: Respiratory research
Issue:: Volume 17:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies. Issue 1 (December 2016)

Authors:: Maltais, François; Kirsten, Anne-Marie; Hamilton, Alan; De Sousa, Dorothy; Voß, Florian; Decramer, Marc
Journal:: Respiratory research
Issue:: Volume 17:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease. (January 2017)

Authors:: Buhl, Roland; Magder, Sheldon; Bothner, Ulrich; Tetzlaff, Kay; Voß, Florian; Loaiza, Lazaro; Vogelmeier, Claus F.; McGarvey, Lorcan
Journal:: Respiratory medicine
Issue:: Volume 122(2017)
Page Start:: 58
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials. (October 2018)

Authors:: Ferguson, Gary T.; Buhl, Roland; Bothner, Ulrich; Hoz, Alberto de la; Voß, Florian; Anzueto, Antonio; Calverley, Peter M.A.
Journal:: Respiratory medicine
Issue:: Volume 143(2018)
Page Start:: 67
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗